RTA Laboratuvarlari Biyolojik (RTALB) — Cash Flow-to-Debt Ratio
RTA Laboratuvarlari Biyolojik (RTALB) has a Cash Flow-to-Debt Ratio of 0.20x as of June 2025, meaning its operating cash flow of TL20.98 Million could theoretically repay 0% of its total liabilities (TL103.51 Million) in one year. See RTALB financial flexibility score to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
RTA Laboratuvarlari Biyolojik Cash Flow-to-Debt Ratio (2010–2024)
Historical debt coverage capacity for RTA Laboratuvarlari Biyolojik across 15 annual periods. For the full cash flow conversion analysis, see RTA Laboratuvarlari Biyolojik operating cash flow efficiency.
Annual Cash Flow-to-Debt Ratio for RTA Laboratuvarlari Biyolojik (2010–2024)
Year-by-year debt coverage analysis for RTA Laboratuvarlari Biyolojik. Check RTALB cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (TRY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.33x | TL-84.45 Million | TL252.17 Million | ▼ -186.8% |
| 2023 | 0.39x | TL72.41 Million | TL187.77 Million | ▲ +129.4% |
| 2022 | -1.31x | TL-140.82 Million | TL107.47 Million | ▼ -498.5% |
| 2021 | 0.33x | TL68.78 Million | TL209.17 Million | ▲ +211.3% |
| 2020 | 0.11x | TL9.37 Million | TL88.72 Million | ▼ -66.1% |
| 2019 | 0.31x | TL3.58 Million | TL11.47 Million | ▲ +148.3% |
| 2018 | -0.65x | TL-5.81 Million | TL8.99 Million | ▼ -506.3% |
| 2017 | 0.16x | TL1.41 Million | TL8.84 Million | ▼ -40.6% |
| 2016 | 0.27x | TL2.86 Million | TL10.69 Million | ▼ -35.6% |
| 2015 | 0.42x | TL6.18 Million | TL14.88 Million | ▲ +83.5% |
| 2014 | 0.23x | TL2.58 Million | TL11.40 Million | ▼ -82.9% |
| 2013 | 1.32x | TL11.26 Million | TL8.52 Million | ▲ +459.3% |
| 2012 | 0.24x | TL2.24 Million | TL9.46 Million | ▼ -5.9% |
| 2011 | 0.25x | TL1.61 Million | TL6.41 Million | ▼ -51.2% |
| 2010 | 0.51x | TL2.78 Million | TL5.39 Million | — |